A new strategy for addressing climate change takes a realistic approach to the challenge of making science useful, says Ryan Meyer.

Questions have been raised about the transparency and scientific quality of regulatory processes applied in the first open field releases of genetically modified (GM) insects, and there is concern that inappropriate precedents have been set, particularly through generic risk assessments covering multiple species and technologies.

Controlling who is allowed access to information about mutations in the H5N1 bird flu virus is unacceptable, says Peter Palese.